Although relatively low serum T3 levels could contribute to these residual manifestations, the higher serum T4:T3 ratio should also be considered. This has been well-established for 4 decades (28, 50, 59), but only recently has it been recognized as a relevant measure given that higher serum T4 levels will impair systemic T3 production via downregulation of a deiodinase pathway (9). Thus, some emphasis has recently been directed toward establishing the clinical significance of this ratio (1, 5).
People who have been treated for hyperthyroidism (underactive thyroid) like Graves' disease, and received radioactive iodine may be left with little or no functioning thyroid tissue after treatment. The likelihood of this depends on a number of factors including the dose of iodine given, along with the size and the activity of the thyroid gland. If there is no significant activity of the thyroid gland six months after the radioactive iodine treatment it usually means that the thyroid gland no longer functioning adequately. The result is hypothyroidism. Similarly, removal of the thyroid gland during surgery cause hypothyroidism.
Correcting these problems requires an integrative approach. It involves more than simply taking a thyroid pill. As you’ll see, it involves nutritional support, exercise, stress reduction, supplements, reducing inflammation, and sometimes eliminating certain foods and detoxification from heavy metals (such as mercury and lead) and petrochemical toxins (such as pesticides and PCBs).
Your thyroid needs iodine to work properly and produce enough TH for your body's needs. Don't get enough iodine, and you run the risk of hypothyroidism or a goiter (a thyroid gland that becomes enlarged to make up for the shortage of thyroid hormone). Most Americans have no problem getting enough iodine, since table salt is iodized—but if you're on a low-sodium diet (as an increasing number of Americans are for their heart health) or follow a vegan diet (more on that later), then you may need to up your intake from other sources.
Major diagnostic and therapeutic advancements in the early 20th century dramatically changed the prognosis of hypothyroidism from a highly morbid condition to one that could be successfully managed with safe, effective therapies. These advancements dictated treatment trends that have led to the adoption of l-thyroxine monotherapy, administered at doses to normalize serum thyroid-stimulating hormone (TSH), as the contemporary standard of care (Figure). Most patients do well with this approach, which both normalizes serum TSH levels and leads to symptomatic remission (1).
Having a thyroid condition is no picnic, but you're not alone with this health issue. According to the American Thyroid Association, more than 12 percent of the population may end up dealing with a thyroid condition at some point in their lives. And thyroid issues can be sneaky: Of the nearly 20 million Americans living with the disease, as many as 60 percent don't even realize they have it.
Affiliate Disclosure: There are links on this site that can be defined as affiliate links. This means that I may receive a small commission (at no cost to you) if you purchase something when clicking on the links that take you through to a different website. By clicking on the links, you are in no way obligated to buy.
Please Note: The material on this site is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any diet or exercise program.
Copyright © livehopelupus.org